Dyne Therapeutics Director Executes $219,000 Stock Sale via Pre-Set Trading Plan
Dirk Kersten, a director at Dyne Therapeutics, Inc. (NASDAQ: DYN), has completed the sale of common stock totaling approximately $219,169. The transactions occurred over two consecutive days in late April 2026 and were conducted under a previously established Rule 10b5-1 trading plan. While the stock has seen recent price fluctuations, including a …